Active Wnt2-V5 Citations (4)

Originally described in: Disulfide Bond Requirements for Active Wnt Ligands.
MacDonald BT, Hien A, Zhang X, Iranloye O, Virshup DM, Waterman ML, He X J Biol Chem. 2014 May 19. pii: jbc.M114.575027. PubMed Journal

---

Articles Citing Active Wnt2-V5

Articles
Sfrp3 modulates stromal-epithelial crosstalk during mammary gland development by regulating Wnt levels. Bernascone I, Gonzalez T, Barea MD, Carabana C, Hachimi M, Bosch-Fortea M, Santamaria S, Martin R, Tarnick J, Garcia-Sanz JA, Martin-Belmonte F. Nat Commun. 2019 Jun 6;10(1):2481. doi: 10.1038/s41467-019-10509-1. PubMed
Thermofluidic heat exchangers for actuation of transcription in artificial tissues. Corbett DC, Fabyan WB, Grigoryan B, O'Connor CE, Johansson F, Batalov I, Regier MC, DeForest CA, Miller JS, Stevens KR. Sci Adv. 2020 Sep 30;6(40). pii: 6/40/eabb9062. doi: 10.1126/sciadv.abb9062. Print 2020 Sep. PubMed
Evidence for a Dual-Pathway, 2-Hit Genetic Model for Focal Cortical Dysplasia and Epilepsy. Bennett MF, Hildebrand MS, Kayumi S, Corbett MA, Gupta S, Ye Z, Krivanek M, Burgess R, Henry OJ, Damiano JA, Boys A, Gecz J, Bahlo M, Scheffer IE, Berkovic SF. Neurol Genet. 2022 Jan 25;8(1):e652. doi: 10.1212/NXG.0000000000000652. eCollection 2022 Feb. PubMed
Tenascin-C Potentiates Wnt Signaling in Thyroid Cancer. Hartmann HA, Loberg MA, Xu GJ, Schwarzkopf AC, Chen SC, Phifer CJ, Caroland K, Chen HC, Diaz D, Tigue ML, Hesterberg AB, Gallant JN, Shaddy SM, Sheng Q, Netterville JL, Rohde SL, Solorzano CC, Bischoff LA, Baregamian N, Hurley PJ, Murphy BA, Choe JH, Huang EC, Ye F, Lee E, Weiss VL. Endocrinology. 2025 Feb 5;166(3):bqaf030. doi: 10.1210/endocr/bqaf030. PubMed

If you have published an article using this material, please email us at to have your article added to this page.